QSCO: Sexual Quality of Patients After Bladder Cancer Cystectomy
Study Details
Study Description
Brief Summary
Bladder cancer is the second most prevalent urological cancer in France. About 1 in 5 new cases of bladder cancer infiltrate the muscles. The standard treatment is neoadjuvant chemotherapy followed by radical cystectomy associated with reconstruction of the urinary tract. The short-term effects on well-being and quality of life are well known. The long-term effects are, on the other hand, poorly understood, particularly sexual function. This study aim to asses the quality of sexual life in patients with cystectomy for bladder cancer. This will be done via various questionnaires given before and after surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The study is a prospective observational cohort study of the quality of sexual life in patients with cystectomy for bladder cancer. Data is collected via Qlq-C30, EORTC-Shq22, MSHQ if male, Female Sexual Function Index (FSFI) questionnaires that the patients complete by themselves. They are given before surgery and then 8 months after surgery.
The study consists of the compilation of relevant clinical data and questionnaire results.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: patients with cystectomy
|
Other: Questionnaires
Patients will fill in multiple questionnaires for this study :
EORTC quality of life questionnaire (QLQ) QLQ-C30, EORTC Shq22, Male Sexual Health Questionnaire (MSHQ) only for Men, FSFI (only for women)
|
Outcome Measures
Primary Outcome Measures
- Evaluation of the decrease in the quality of sexual life of patients who had a cystectomy [T0 : before surgery]
EORTC SHQ C22 score before surgery
- Evaluation of the decrease in the quality of sexual life of patients who had a cystectomy [T1 : 8 months after surgery]
EORTC SHQ C22 score 8 months after surgery
Secondary Outcome Measures
- Evaluation of the decrease in the quality of life of patients who had a cystectomy [T0 : before surgery]
QLQ-C30 score before surgery
- Evaluation of the decrease in the quality of life of patients who had a cystectomy [T1 : 8 months after surgery]
QLQ-C30 score 8 months after surgery
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Any adult patient who had a cystectomy for bladder cancer
-
Affiliated with a social security scheme
Exclusion Criteria:
-
No Cystectomy
-
Cystectomy for neurological etiology
-
Pregnant or breastfeeding women
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Toulouse | Toulouse | France |
Sponsors and Collaborators
- University Hospital, Toulouse
Investigators
- Principal Investigator: Eric Huyghe, MD, University Hospital, Toulouse
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RC31/21/0113